Blood myeloperoxidase‐DNA, a biomarker of early response to SARS‐CoV‐2 infection? - Université de Lorraine Access content directly
Journal Articles Allergy Year : 2021

Blood myeloperoxidase‐DNA, a biomarker of early response to SARS‐CoV‐2 infection?

Abstract

Convergent arguments suggest that innate immunity related to neutrophils, and in particular neutrophil extracellular traps (NETs), could play a key role in response to SARS-CoV-2 infection.

Dates and versions

hal-02928662 , version 1 (22-09-2023)

Identifiers

Cite

Jean‐louis Guéant, Julien Fromonot, Rosa‐maria Guéant‐rodriguez, Patrick Lacolley, Régis Guieu, et al.. Blood myeloperoxidase‐DNA, a biomarker of early response to SARS‐CoV‐2 infection?. Allergy, 2021, 76 (3), pp.892-896. ⟨10.1111/all.14533⟩. ⟨hal-02928662⟩
128 View
1 Download

Altmetric

Share

Gmail Facebook X LinkedIn More